GL1X · GenesisL1 explorer

MolNFT v1 · #117855 · protein

Crystal structure of MAPK13 complex with inhibitor

5EKN · Mitogen-activated protein kinase 13: “Crystal structure of MAPK13 complex with inhibitor”. X-ray diffraction, 1 ligand (N58), 1 pocket (best druggability 0.74). MolNFT v1 #117855 on GenesisL1: 3D structure, binding sites and pockets…

PDB
5EKN
Type
protein
Length
336 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Mitogen-activated protein kinase 13
EC
2.7.11.24
UniProt
O15264
Ligands
N58
Pockets
1 · best druggability 0.74

Structure

x-ray diffraction · 1 distinct chain · 37% helix, 15% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AMitogen-activated protein kinase 13 (EC 2.7.11.24)protein33637% helix, 15% strandO15264

Ligands and binding sites

  • N58 · 1-(3-tert-butyl-1-methyl-1H-pyrazol-5-yl)-3-[4-(pyridin-4-ylsulfanyl)phenyl]urea · ligand · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

1 pocket found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
15260.740.8246N58

Compared structures

  • 5EKN · Crystal structure of MAPK13 complex with inhibitor · the same entry in another collection · chain A against A, TM-score 1.00
  • O15264 · AlphaFold monomer V2.0 prediction for mitogen-activated protein kinase 13 (O15264) · a predicted model of the same protein · chain A against A, TM-score 0.97

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.